RETRACTED: Wiesinger et al. An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis. <i>Pharmaceutics</i> 2023, <i>15</i>, 1565
Anna-Maria Wiesinger,
Brian Bigger,
Roberto Giugliani,
Christina Lampe,
Maurizio Scarpa,
Tobias Moser,
Christoph Kampmann,
Georg Zimmermann,
Florian B. Lagler
Affiliations
Anna-Maria Wiesinger
Institute of Congenital Metabolic Diseases, Paracelsus Medical University, 5020 Salzburg, Austria
Brian Bigger
European Reference Network for Hereditary Metabolic Diseases, MetabERN, 33100 Udine, Italy
Roberto Giugliani
Department of Genetics, Medical Genetics Service and Biodiscovery Laboratory, Portal Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Casa dos Raros, Porto Alegre 90610-261, Brazil
Christina Lampe
European Reference Network for Hereditary Metabolic Diseases, MetabERN, 33100 Udine, Italy
Maurizio Scarpa
European Reference Network for Hereditary Metabolic Diseases, MetabERN, 33100 Udine, Italy
Tobias Moser
Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria
Christoph Kampmann
Department of Pediatric Cardiology, University Hospital Mainz, 55131 Mainz, Germany
Georg Zimmermann
Team Biostatistics and Big Medical Data, IDA Lab Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria
Florian B. Lagler
Institute of Congenital Metabolic Diseases, Paracelsus Medical University, 5020 Salzburg, Austria
